Published • loading... • Updated
Castle Biosciences (NASDAQ:CSTL) Stock Rating Cut to “Hold” at Wall Street Zen
Summary by thecerbatgem.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Castle Biosciences (NASDAQ:CSTL) Stock Rating Cut to “Hold” at Wall Street Zen
Castle Biosciences (NASDAQ:CSTL – Get Free Report) was downgraded by research analysts at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued on Saturday, Wall Street Zen reports. Other equities analysts have also recently issued reports about the company. Weiss Ratings upgraded Castle Biosciences from a “sell (e+)” […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
